Trasylol (Aprotinin, BAYA0128)

DRUG4 trials

Sponsors

Bayer

Conditions

Blood Loss, SurgicalPostoperative Hemorrhage

Phase 3

Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer

TerminatedNCT00306137

BayerBlood Loss, Surgical

Start: 2005-12-31End: 2007-03-31Updated: 2014-12-09

Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

TerminatedNCT00306150

BayerBlood Loss, Surgical, Postoperative Hemorrhage

Start: 2005-12-31End: 2007-03-31Updated: 2014-12-17

Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

TerminatedNCT00327379

BayerBlood Loss, Surgical, Postoperative Hemorrhage

Start: 2006-02-27End: 2007-03-01Updated: 2019-06-04

Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement

CompletedNCT00668031

BayerBlood Loss, Surgical

Start: 2005-02-28End: 2006-01-31Updated: 2014-12-30